Ignite Creation Date:
2024-05-06 @ 7:50 PM
Last Modification Date:
2024-10-26 @ 3:15 PM
Study NCT ID:
NCT06153251
Status:
RECRUITING
Last Update Posted:
2024-05-10
First Post:
2023-11-22
Brief Title:
A Study to Assess BMS-986453 in Participants With Relapsed andor Refractory Multiple Myeloma
Sponsor:
Juno Therapeutics Inc a Bristol-Myers Squibb Company
Organization:
Juno Therapeutics Inc a Bristol-Myers Squibb Company
Key Dates - Follows AllAPIJSON File Order
Start Date:
2024-01-23
Start Date Type:
ACTUAL
Primary Completion Date:
2027-11-29
Primary Completion Date Type:
ESTIMATED
Completion Date:
2027-11-29
Completion Date Type:
ESTIMATED
First Submit Date:
2023-11-22
First Submit QC Date:
November 22 2023
Study First Post Date:
2023-12-01
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2024-09-12
Last Update Post Date:
2024-05-10
Last Update Post Date Type:
ACTUAL